Red Flags Detected

  • Auditor Change (new) — Company switched from Bush & Associates to M&K CPAS for 2025; new auditor identified revenue recognition as critical audit matter while prior auditor reported none.
  • Asset Impairment (new) — Recorded $1.75M intangible asset impairment (46% of prior balance) after determining certain product licenses could not be commercialized.
NASDAQ: SBFMW Sunshine Biopharma Inc. 10-K

Sunshine Biopharma cuts pipeline 66%, faces $5.3M legal claim, narrows loss despite revenue growth

Filed April 3, 2026 · Period ending December 31, 2025 · Compared to 10-K Apr 1, 2025 · ~2 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade SBFMW commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.